OncoDNA

𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗻𝗴 𝗮 𝘆𝗲𝗮𝗿 𝗳𝘂𝗹𝗹 𝗼𝗳 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀! 🙌 In #2024, OncoDNA reached a significant milestone by strengthening partnerships with key players in the oncology field. These strategic collaborations are bringing us closer to our vision: becoming the preferred partner for laboratories and clinicians in personalized medicine. From developing innovative solutions like the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 to establishing strong alliances, 𝗶𝘁’𝘀 𝗯𝗲𝗲𝗻 𝗮 𝘆𝗲𝗮𝗿 𝗼𝗳 𝗴𝗿𝗼𝘄𝘁𝗵 𝗮𝗻𝗱 𝗮𝗺𝗯𝗶𝘁𝗶𝗼𝗻. A huge thank you to our partners for their trust! Together, we are shaping the future of oncology care. 🙏 Wishing you a wonderful holiday season, and see you in #2025 for even more shared successes! 💫

𝗡𝗶𝗰𝗲 𝘀𝘁𝗼𝗿𝘆 𝘁𝗼 𝗲𝗻𝗱 𝘁𝗵𝗶𝘀 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝘆𝗲𝗮𝗿! It took only three months from Jean-Pol Detiffe's visit during his holidays to convince this Turkish lab to test the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 CGP solution. This week, our FAS, Karim Ashour Garrido, trained the entire lab team and prepared them to seamlessly use our solution in their routine practice! 🔬 🧬 #CGP #Precisionmedicine #Lab #Cancercare #Genomic

𝗡𝗶𝗰𝗲 𝘀𝘁𝗼𝗿𝘆 𝘁𝗼 𝗲𝗻𝗱 𝘁𝗵𝗶𝘀 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝘆𝗲𝗮𝗿! It took only three months from Jean-Pol Detiffe's visit during his holidays to convince this Turkish lab to test the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 CGP solution. This week, our FAS, Karim Ashour Garrido, trained the entire lab team and prepared them to seamlessly use our solution in their routine practice! 🔬 🧬 #CGP #Precisionmedicine #Lab #Cancercare #Genomic

🌟 Missed our latest webinar? Don’t worry—you can watch it on demand!   In this session, Dr. Marcel Trautmann shared his inspiring business case on integrating the #OncoDEEP CGP solution into routine practice.   💡 Don’t miss the insightful Q&A, where Dr. Trautmann addresses these key topics and more, offering practical tips for transitioning to an efficient new workflow. 🕒 38 min: Defining the number of samples for internal validation and expert advice on validation best practices. 💻 41 min: How the OncoKDM clinical decision support platform simplifies your workflow and improves efficiency. 🕒 45 min: Step-by-step insights into the OncoDEEP Kit workflow and how to implement it seamlessly—even from scratch. 📊 51 min: Preparing your own business case: What to include and why it matters. 👉 Watch it now: https://lnkd.in/eXGXciHW #Oncology #CGP #OncoDEEP #OncoKDM #WebinarOnDemand

𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 solution highlighted in a comparison study conducted by a global expert consensus and published in the 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗼𝗳 𝗖𝗮𝗻𝗰𝗲𝗿: "𝙃𝙤𝙢𝙤𝙡𝙤𝙜𝙤𝙪𝙨 𝙧𝙚𝙘𝙤𝙢𝙗𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙙𝙚𝙛𝙞𝙘𝙞𝙚𝙣𝙘𝙮 𝙞𝙣 𝙤𝙫𝙖𝙧𝙞𝙖𝙣 𝙘𝙖𝙣𝙘𝙚𝙧: 𝙂𝙡𝙤𝙗𝙖𝙡 𝙚𝙭𝙥𝙚𝙧𝙩 𝙘𝙤𝙣𝙨𝙚𝙣𝙨𝙪𝙨 𝙤𝙣 𝙩𝙚𝙨𝙩𝙞𝙣𝙜 𝙖𝙣𝙙 𝙖 𝙘𝙤𝙢𝙥𝙖𝙧𝙞𝙨𝙤𝙣 𝙤𝙛 𝙘𝙤𝙢𝙥𝙖𝙣𝙞𝙤𝙣 𝙙𝙞𝙖𝙜𝙣𝙤𝙨𝙩𝙞𝙘𝙨." 👏 https://lnkd.in/eCysh_U3 Do you know that #HRD testing is integral to the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 solution? No extra purchase is needed! https://lnkd.in/e2qST-Ez

We are delighted to welcome Jean-Baptiste Mariaux to OncoDNA as the new 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗗𝗔𝗖𝗛 𝗿𝗲𝗴𝗶𝗼𝗻. With over 20 years of experience in genomics, working with companies such as IDT, Qiagen, and Thermo Fisher, Jean-Baptiste has established strong partnerships in the DACH region, Benelux, and France. He aims to support our growth in this region. Welcome aboard, Jean-Baptiste - we look forward to achieving great things together! 👏 #WelcomeToTheTeam #OncoDNA #PrecisionMedicine

🔬 [𝗩𝗼𝗶𝗰𝗲 𝗢𝗳 𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿 - 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟮] 🗣️ In this episode, Pr. Daniela Cesselli explains the strategic needs that drove the adoption of a CGP panel and the reasons behind choosing the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 solution. 🤔 Was it to ensure timely results while covering 𝗛𝗥𝗗, 𝗧𝗠𝗕, 𝗮𝗻𝗱 𝗠𝗦𝗜 testing? To leverage an optimized workflow that enables labs to sequence more samples within the same timeframe? Or perhaps for its responsive support, which operates like a true "guardian angel"? 😇 Find the answer here below👇 Great collaboration success between Devyser, 𝗔𝗦𝗨 𝗙𝗖 𝗨𝗱𝗶𝗻𝗲 and OncoDNA. 🤝

𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣 𝗞𝗶𝘁 𝗯𝗲𝘆𝗼𝗻𝗱 𝗲𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗯𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀! 🌏 Jean-Pol Detiffe and Jessie Hong are in Taipei this week, representing OncoDNA as part of the Belgian delegation at the Healthcare+ Expo Taiwan 2024. 🇹🇼 With many exciting and promising meetings, there’s growing enthusiasm for the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣 𝗖𝗚𝗣 panel. We can’t wait to see how many hospitals will embrace our solution in the coming months, advancing personalized oncology care worldwide! 🏥💡 Thank you, Philippe Tzou and Alex Wang, for your steadfast support! 🙏 Stay tuned for more updates!

🗓️ Reminder: 6 days before our webinar! Join us on December 11, 2024, at 4:00 PM CET for a live discussion on the business case for Comprehensive Genomic Profiling (CGP). Speaker: Dr. Marcel Trautmann Topics: ➡️ Challenges and successes in implementing CGP ➡️ Using CGP to uncover actionable treatment options ➡️ Building a sustainable approach for CGP in your lab Don’t miss this opportunity to gain practical insights from real-world applications of CGP in oncology. ⏳ There’s still time to register: https://lnkd.in/eFHHGPTd #OncoDNA #GenomicProfiling #Oncology #Webinar #PrecisionMedicine #HealthcareInnovation #CGP

We're extremely pleased to share groundbreaking research published in Oral Oncology, highlighting the transformative role of liquid biopsy and circulating tumor DNA (ctDNA) in understanding molecular heterogeneity and monitoring relapse in head and neck cancer. For this study led by Institut Curie, OncoDNA was chosen as a trusted partner for its precise liquid biopsy-based monitoring solution. This cutting-edge approach delivers timely, non-invasive insights into tumor dynamics, paving the way for more effective, personalized cancer treatments. This minimal residual disease (MRD) approach applied to the circulating DNA will remain the same in our 𝗻𝗲𝘄 𝗢𝗻𝗰𝗼𝗙𝗢𝗟𝗟𝗢𝗪™ solution, now leveraging Twist Bioscience's MRD 500 technology. Interested? Contact our team! 👏 Congratulations to the outstanding team: Berengere Genin, Sébastien Sauvage, Cédric Balsat, Aubray Prévot, Maxime LIENARD, and everyone at OncoDNA and IntegraGen for their significant contribution! Read the article: https://lnkd.in/ezrUnSCP #LiquidBiopsy #ctDNA #PrecisionMedicine